MDxHealth SA (OTCMKTS:MXDHF – Get Free Report)’s stock price dropped 9.1% on Tuesday . The stock traded as low as $0.25 and last traded at $0.25. Approximately 300 shares traded hands during trading, a decline of 70% from the average daily volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Stock Performance
The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.19 and a current ratio of 1.25. The stock has a fifty day simple moving average of $0.43.
MDxHealth Company Profile
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Recommended Stories
- Five stocks we like better than MDxHealth
- The Most Important Warren Buffett Stock for Investors: His Own
- Silicon Motion Proves That AI in Motion Stays in Motion
- Industrial Products Stocks Investing
- Undervalued UnitedHealth Group Won’t Be For Long
- Breakout Stocks: What They Are and How to Identify Them
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.
